Copthorne Tara Hotel
3D cell culture is gaining momentum in the pharmaceutical industry, with the global market for this technology expected to surpass $3.2 billion by 2027. Researchers globally are realising the potential of in vitro applications for drug discovery, predictivity, validation and safety.
SMi's 5th annual 3D cell culture conference will be covering the application of 3D cell culture to drug development, toxicity testing and safety assurance. In addition, the conference will look into the latest developments in organ chip technology, 3D multicellular scaffolding, microphysiological systems and 3D bioprinting. In recent years, the advance in technology has made these tools accessible for use for scientific applications.